Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Showing posts with label Rasch Measurement Theory. Show all posts
Showing posts with label Rasch Measurement Theory. Show all posts

Sunday, July 20, 2025

Measuring arm function early after stroke: is the DASH good enough?

 When will you understand; 'measurements' DO NOTHING FOR RECOVERY?

Measuring arm function early after stroke: is the DASH good enough?


Karen Baker 1 Louise Barrett 2 E Diane Playford 1 Trefor Aspden Afsane Riazi 3 Jeremy Hobart 2 Correspondence to Professor Jeremy Hobart, Clinical Neurology Research Group, Plymouth University Peninsula Schools of Medicine and Dentistry, Room N13 ITTC Building, Plymouth Science Park, Derriford, Plymouth PL6 8BX, UK; 

Abstract

Objective Despite a growing call to use patient-reported outcomes in clinical research, few are available for measuring upper limb function post-stroke. We examined the Disabilities of the Arm, Shoulder and Hand (DASH) to evaluate its measurement performance in acute stroke. In doing so, we compared results from traditional and modern psychometric methods.

Methods 172 people with acute stroke completed the DASH. Those with upper limb impairments completed the DASH again at 6 weeks (n=99). Data (n=271) were analysed using two psychometric paradigms: traditional psychometric (Classical Test Theory, CTT) analyses examined data completeness, scaling assumptions, targeting, reliability and responsiveness; Rasch Measurement Theory (RMT) analyses examined scale-to-sample targeting, scale performance and person measurement.

Results CTT analyses implied the DASH was psychometrically robust in this sample. Data completeness was high, criteria for scaling assumptions were satisfied (item-total correlations 0.55–0.95), targeting was good, internal consistency reliability was high (Cronbach's α=0.99) and responsiveness was clinically moderate (effect size=0.51). However, RMT analyses identified important limitations: scale-to-sample targeting was suboptimal, 4 items had disordered response category thresholds, 16 items exhibited misfit, 3 pairs of items had high residual correlations (>0.60) and 84 person fit residuals exceeded the recommended range.

Conclusions RMT methods identified limitations missed by CTT and indicate areas for improvement of the DASH as an upper limb measure for acute stroke. Findings, similar to those identified in multiple sclerosis, highlight the need for scales to have strong conceptual underpinnings, with their development and modification guided by sophisticated psychometric methods.

Monday, March 16, 2020

Comprehensive ADL outcome measurement after stroke: Rasch validation of the Lucerne ICF-based multidisciplinary observation scale (LIMOS)

This is so fucking simple. One question to the survivor.

Did you get 100% recovered? Yes/No?

Comprehensive ADL outcome measurement after stroke: Rasch validation of the Lucerne ICF-based multidisciplinary observation scale (LIMOS)

Archives of Physical Medicine and Rehabilitation , Volume 100(12) , Pgs. 2314-2323.

NARIC Accession Number: J82785.  What's this?
ISSN: 0003-9993.
Author(s): Van den Winckel, Ann; Ottiger, Beatrice; Bohlhalter, Stephan; Nyffeler, Thomas; Vanbellingen, Tim.
Publication Year: 2019.
Number of Pages: 10.

Abstract: 

Study used Rasch Measurement Theory (RMT) to establish the validity of the Lucerne International Classification of Functioning, Disability and Health (ICF)-based Multidisciplinary Observation Scale (LIMOS) in stroke. LIMOS measures the level of assistance in daily life activities related to motor function, communication, cognition, and domestic life. RMT transforms an ordinal scale into an interval scale and thus the Rasch-based LIMOS scale captures a more accurate improvement of functional outcomes via Rasch-transformed scores. A total of 407 participants with stroke, recruited from a neurorehabilitation center in Luzerne, Switzerland, were assessed with LIMOS at admission and discharge of rehabilitation. RMT was used to evaluate overall model fit, response dependency, floor and ceiling effect, reliability, and differential item functioning (DIF) for sex, age, type, and time of stroke on the 4 LIMOS subscales using the Rasch Unidimensional Measurement Model 2030 program. The Rasch-based LIMOS subscales fit the Rasch model after reducing and rescoring items: motor (from 20 to 18 items), communication (5 items), cognition (from 15 to 13 items), and domestic life (5 items). There was no floor or ceiling effect. Some artificial DIF was identified. Scoring at discharge was dependent on the scoring responses at admission, which means that without applying a correction factor to the discharge scores, there was an underestimation of change in scores between admission and discharge, ranging from 0.24 to 0.97 logits on the different subscales. The Rasch-based LIMOS scale is recommended to measure functional outcome in people with acute or chronic stages of ischemic or hemorrhagic stroke.
Descriptor Terms: DAILY LIVING, MEASUREMENTS, OUTCOMES, PERFORMANCE STANDARDS, STROKE.


Can this document be ordered through NARIC's document delivery service*?: Y.

Citation: Van den Winckel, Ann, Ottiger, Beatrice, Bohlhalter, Stephan, Nyffeler, Thomas, Vanbellingen, Tim. (2019). Comprehensive ADL outcome measurement after stroke: Rasch validation of the Lucerne ICF-based multidisciplinary observation scale (LIMOS).  Archives of Physical Medicine and Rehabilitation , 100(12), Pgs. 2314-2323. Retrieved 3/16/2020, from REHABDATA database.


* The majority of journal articles, books, and reports in our collection are only available by regular mail, rather than downloadable electronic format. Learn more about our digital collection and our document delivery service.